Intelligence

#Automation / robotics #Drug discovery

Whitepaper: Bespoke Biosafety: Building a Custom Biosafety Cabinet

Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases, the equipment may actually interfere with the cabinet’s airflow, creating turbulence and rendering the cabinet ineffective. Download this whitepaper about customised… Read More

#Whitepapers

CRISPR eBook cover
#CRISPR #CRISPR-Cas9 #Drug discovery #eBook #Gene editing #Genetics / genomics

Gene editing & CRISPR: Advances in applications and opportunity

This eBook explores the latest innovations in gene editing and CRISPR, the possibilities of new editing techniques and where the greatest potential for the technology might lie in the future. Download this exclusive eBook to learn more about: How CRISPR is providing new solutions for common diseases; The potential of base editing… Read More

#DDW eBooks #Intelligence

#Advanced Therapies

eBook: Gene editing & CRISPR: Advances in applications and opportunity

This 24-page eBook sponsored by Scale Biosciences explores the latest innovations in gene editing and CRISPR, the possibilities of new editing techniques and where the greatest potential for the technology might lie in the future. Download this exclusive eBook to learn more about:   How CRISPR is providing new solutions for… Read More

#DDW eBooks

Someone using a keyboard
#AI / data analytics / healthtech / informatics #Data management #Informatics #Market reporting

Drug discovery informatics market predicted to grow 12.6% by 2028

The drug discovery informatics market is predicted to grow from $3.77 billion in 2024 to $6.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%, according to analysts ResearchAndMarkets.com. The recent growth in the market is attributed to advancements in genomics and proteomics,… Read More

#Business & Investment #Market Reports #News #Trends & Analysis

Drug discovery technology
#2024 predictions #Antibody drug conjugate (ADC) #Artificial intelligence (AI) #Gene therapy

Key drug development trends and predictions for 2024

Dr Julie Warner is Vice President of Regulatory Affairs at drug development consultancy, Boyds. In this article, she provides her expert insights into the key trends and developments expected to shape the global drug development industry this year. Financial landscape In 2023, life science companies experienced… Read More

#Exclusive Content #Trends & Analysis

2024 predictions, road forward
#2024 predictions #AI / data analytics / healthtech / informatics #Antiverse #Artificial intelligence (AI) #Drug discovery #Elsevier #Enhanc3D Genomics #IQVIA #Lab automation #Machine learning #Medidata #Ori Biotech #Technology #TrakCel #Trinity Life Sciences

2024 predictions: Experts comment on AI, ML and automation

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Cell Science

Whitepaper: Using patient-specific cells for disease modelling

Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients and have the potential to guide these cells towards multiple lineages.   Download the Whitepaper to: Explore iPSC-derived motor neuron morphology Discover how ALS disease phenotype is… Read More

#Whitepapers

2024 predictions, road forward
#2024 predictions #AstraZeneca #BioSenic #Cancer #Drug discovery #Mosaic Therapeutics #Oncology #OrganaBio #Phesi #Therapeutics

2024 predictions: Experts weigh in on cancer research

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on what to expect from cancer research and immunotherapies. Greg Rossi, Senior Vice… Read More

#Cancer Research #Exclusive Content #Opinion #Trends & Analysis

View from the International Space Station
#Antibodies #BioOrbit #Manufacturing #Start-ups #Therapeutic Antibodies

Why Carol Vorderman’s daughter is taking antibodies into space

A UK-based start-up is developing technology to build a pharmaceuticals factory in space that will make antibody treatments more accessible and easier to administer. BioOrbit is aiming to build the first pharmaceuticals factory in microgravity and are currently developing a platform for large-scale crystallisation of protein… Read More

#Editor's Choice #News #Start-up Zone

#Therapeutic Antibodies

Guide: Therapeutic Antibodies Guide Twist

DDW has published the latest edition in its guide series ‘The global innovation and opportunity in therapeutic antibody development’.   The DDW Therapeutic Antibodies Guide looks at the trajectory of antibody therapies in 2024 and use-cases across disease areas.  Download to learn about:   Therapeutic antibody potential in 2024  Therapeutic antibodies… Read More

#DDW Guides

#Biologics #Drug discovery #Infographic #Nanomedicine / nanotechnology #Proteins

Four methods for thermal stability assessment of proteins

Thermal stability is among the most common critical quality attributes (CQAs) used for early developability assessment of biologics. In this infographic, learn about four methods for thermal stability assessment of proteins – what they measure, what the data tells you, and their benefits and limitations. While each provides unique value,… Read More

#Intelligence #Resources

#Drug development #Drug discovery #Guide #Therapeutic Antibodies

DDW Therapeutic Antibody Guide 2024

Download the exclusive Guide and read about: The global innovation in therapeutic antibody development and the opportunities being created What does the therapeutic antibody sector need to overcome challenges and get to market faster? Industry insight and forecasts… Read More

#DDW eBooks #DDW Guides

#Biopharmaceuticals #Clarivate #Drug development #Drug discovery #Market reporting

Thirteen potential blockbuster drugs to watch in 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. They include therapeutics for conditions including breast cancer, haemophilia A, sickle cell disease, Crohn’s disease, ulcerative colitis, respiratory syncytial virus (RSV) and multiple myeloma, among… Read More

#News #Trending News #Trends & Analysis